Literature DB >> 36073682

Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study.

Lin Li1,2, Zheng Chang2, Jiangwei Sun2,3, Miguel Garcia-Argibay1, Ebba Du Rietz2, Maja Dobrosavljevic1, Isabell Brikell2, Tomas Jernberg4, Marco Solmi5,6,7,8, Samuele Cortese8,9,10, Henrik Larsson1,2.   

Abstract

Accumulating evidence suggests a higher risk for cardiovascular diseases among individuals with mental disorders, but very little is known about the risk for overall and specific groups of cardiovascular diseases in people with attention-deficit/hyperactivity disorder (ADHD). To fill this knowledge gap, we investigated the prospective associations between ADHD and a wide range of cardiovascular diseases in adults. In a nationwide population-based cohort study, we identified 5,389,519 adults born between 1941 and 1983, without pre-existing cardiovascular diseases, from Swedish registers. The study period was from January 1, 2001 to December 31, 2013. Incident cardiovascular disease events were identified according to ICD codes. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated using Cox proportional hazards regression model, with ADHD as a time-varying exposure. After an average 11.80 years of follow-up, 38.05% of individuals with ADHD versus 23.57% of those without ADHD had at least one diagnosis of cardiovascular disease (p<0.0001). ADHD was significantly associated with increased risk of any cardiovascular disease (HR=2.05, 95% CI: 1.98-2.13) after adjusting for sex and year of birth. Further adjustments for education level, birth country, type 2 diabetes mellitus, obesity, dyslipidemia, sleep problems and heavy smoking attenuated the association, which however remained significant (HR=1.84, 95% CI: 1.77-1.91). Further adjustment for psychiatric comorbidities attenuated but could not fully explain the association (HR=1.65, 95% CI: 1.59-1.71). The strongest associations were found for cardiac arrest (HR=2.28, 95% CI: 1.81-2.87), hemorrhagic stroke (HR=2.16, 95% CI: 1.68-2.77), and peripheral vascular disease/arteriosclerosis (HR=2.05, 95% CI: 1.76-2.38). Stronger associations were observed in males and younger adults, while comparable associations were found among individuals with or without psychotropic medications and family history of cardiovascular diseases. These data suggest that ADHD is an independent risk factor for a wide range of cardiovascular diseases. They highlight the importance of carefully monitoring cardiovascular health and developing age-appropriate and individualized strategies to reduce the cardiovascular risk in individuals with ADHD.
© 2022 World Psychiatric Association.

Entities:  

Keywords:  Attention-deficit/hyperactivity disorder; arteriosclerosis; cardiac arrest; cardiovascular diseases; hemorrhagic stroke; peripheral vascular disease; psychiatric comorbidities; psychotropic medications

Year:  2022        PMID: 36073682      PMCID: PMC9453905          DOI: 10.1002/wps.21020

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   79.683


  59 in total

Review 1.  ADHD in adults: a review of the literature.

Authors:  Megan A Davidson
Journal:  J Atten Disord       Date:  2007-12-19       Impact factor: 3.256

Review 2.  Schizophrenia and increased risks of cardiovascular disease.

Authors:  Charles H Hennekens; Alissa R Hennekens; Danielle Hollar; Daniel E Casey
Journal:  Am Heart J       Date:  2005-12       Impact factor: 4.749

3.  Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study.

Authors:  Samuele Cortese; Shihua Sun; Junhua Zhang; Esha Sharma; Zheng Chang; Ralf Kuja-Halkola; Catarina Almqvist; Henrik Larsson; Stephen V Faraone
Journal:  Lancet Psychiatry       Date:  2018-07-24       Impact factor: 27.083

4.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.

Authors:  Amanda Nicholson; Hannah Kuper; Harry Hemingway
Journal:  Eur Heart J       Date:  2006-11-02       Impact factor: 29.983

Review 5.  Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.

Authors:  Hui Liu; Wenjing Feng; Dongfeng Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-08-24       Impact factor: 4.785

6.  Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.

Authors:  Jari Tiihonen; Ellenor Mittendorfer-Rutz; Minna Torniainen; Kristina Alexanderson; Antti Tanskanen
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

Review 7.  The pathophysiology of cigarette smoking and cardiovascular disease: an update.

Authors:  John A Ambrose; Rajat S Barua
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

8.  Assessing the Mental Health of Brazilian Students Involved in Risky Behaviors.

Authors:  Daise Fernanda Santos Souza Escobar; Priscilla Rayanne E Silva Noll; Thaís Ferreira de Jesus; Matias Noll
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

Review 9.  The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research.

Authors:  Jonas F Ludvigsson; Pia Svedberg; Ola Olén; Gustaf Bruze; Martin Neovius
Journal:  Eur J Epidemiol       Date:  2019-03-30       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.